Share

August 2019; 9 (4) Review

Therapy for acute nerve agent poisoning

An update

Jonathan Newmark
First published April 23, 2019, DOI: https://doi.org/10.1212/CPJ.0000000000000641
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
334

Share

Article Information

vol. 9 no. 4 337-342
DOI: 
https://doi.org/10.1212/CPJ.0000000000000641
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received October 23, 2018
  • Accepted February 1, 2019
  • First Published April 23, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Jonathan Newmark, MD, MM
  1. Jonathan Newmark, MD, MM
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. I am a composer. I have five works published by two separate publishers. I have miniscule (less than $100/year) publishing royalties. These are of NO relevance to this work. My publishers are Trevco-Varner (Tallevast, Florida) and BrassArts Unlimited (Lutherville, Maryland).

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Joint Research and Development Inc., Stafford, Virginia 2. National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 3. National Institute of Allergy and Infectious Diseases, Rockville, Maryland 4. Office of the Governor, Commonwealth of Virginia, Richmond, Virginia (Governor's Secure and Resilient Commonwealth Panel)

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD; Department of Neurology, School of Medicine and Health Sciences, George Washington University; and Department of Neurology, Washington DC Veterans' Affairs Medical Center.
  1. Correspondence
    Dr. Newmark jnviola{at}verizon.net
View Full Text

Article usage

Article usage: April 2019 to April 2023

AbstractFullPdfSource
Apr 201987013Highwire
May 201973012Highwire
Jun 201970020Highwire
Jul 20194208Highwire
Aug 20195895459Highwire
Sep 20194923919Highwire
Oct 20198864027Highwire
Nov 20192753815Highwire
Dec 201915929Highwire
Jan 2020275621Highwire
Feb 20208309Highwire
Mar 202096311Highwire
Apr 2020112114Highwire
May 2020173313Highwire
Jun 20205024Highwire
Jul 202065114Highwire
Aug 20205027Highwire
Sep 202091311Highwire
Oct 202010619Highwire
Nov 202012714Highwire
Dec 20205161Highwire
Jan 20212400Highwire
Feb 20212316Highwire
Mar 20216533Highwire
Apr 20213531Highwire
May 20214958Highwire
Jun 20213011Highwire
Jul 20214323Highwire
Aug 20216511Highwire
Sep 20216271Highwire
Oct 20218912Highwire
Nov 20214922Highwire
Dec 20216600Highwire
Jan 20223300Highwire
Feb 20223820Highwire
Mar 20224000Highwire
Apr 20222900Highwire
May 20225721Highwire
Jun 20223911Highwire
Jul 20222211Highwire
Aug 20224310Highwire
Sep 20224221Highwire
Oct 20225910Highwire
Nov 20229030Highwire
Dec 20224201Highwire
Jan 20238200Highwire
Feb 20235300Highwire
Mar 20239701Highwire
Apr 20237300Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles